Notice 20 May 2025 postal service, regulatory compliance, business agreements, competitive products

📦Postal Regulatory Commission Notice on New Postal Products

The Commission is noticing a recent Postal Service filing for the Commission's consideration concerning a negotiated service agreement. This notice informs the public of the filing, invites public comment, and takes other administrative steps.

Learn More
Notice 20 May 2025 wildlife conservation, regulatory compliance, marine research, noaa, marine mammals

🐬Business Implications of Marine Mammal Protection Act Permit Amendment

Notice is hereby given that Douglas Nowacek, Ph.D., Duke University, Nicholas School of the Environment, Duke University Marine Laboratory, 135 Duke Marine Lab Rd., Beaufort, NC 28516, has been issued a minor amendment to Scientific Research Permit No. 22156-05.

Learn More
Notice 20 May 2025 financial markets, securities, regulatory compliance, bitcoin, options trading, cboe

💰Cboe Exchange Bitcoin Trust Options Trading Rule Change Notice

The SEC is reviewing a proposed rule change by Cboe Exchange to allow the listing and trading of options on the VanEck Bitcoin Trust. The proposal has undergone several amendments and will be evaluated by the SEC by July 2, 2025. This extension aims to ensure adequate consideration of the regulatory implications involved.

Learn More
Notice 19 May 2025 fishing, regulatory compliance, economic impact, hawaii, fishery management, noaa, public meetings

🎣Public Meetings on Fishery Management by Western Pacific Council

The Western Pacific Fishery Management Council (Council) will hold its 156th Scientific and Statistical Committee (SSC), Executive and Budget Standing Committee (SC), Fishery Data Collection and Research Committee (FDCRC), Pelagic and International SC, Military Expansion SC, and its 203rd Council meeting to take actions on fishery management issues in the Western Pacific Region.

Learn More
Notice 19 May 2025 regulatory compliance, healthcare, data collection, infection prevention, ahrq

🏥Proposed Information Collection on Infection Prevention in Healthcare

This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project (new): "The AHRQ Safety Program for Healthcare Associated Infection Prevention." This proposed information collection was previously published in the Federal Register on November 20, 2024 and allowed 60 days for public comment. AHRQ received comments from members of the public. The purpose of this notice is to allow an additional 30 days for public comment.

Learn More
Notice 19 May 2025 regulatory compliance, u.s., banking, mergers, acquisitions, federal reserve

🏦Federal Reserve Notice on Bank Holding Companies and Mergers

The Federal Reserve System issues a notice regarding the applications for bank holding company formations, acquisitions, and mergers. The notice invites public comments on the applications, emphasizing transparency and compliance with the Bank Holding Company Act and related regulations. Applications are available for public inspection, providing insights into ongoing banking transactions.

Learn More
Notice 19 May 2025 regulatory compliance, public meeting, drug manufacturing, fda, healthcare, generic drugs, user fees

💊FDA Announces Public Meeting on Generic Drug User Fee Reauthorization

The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2028 to 2032. At the end of September 2027, new legislation will be required for FDA to continue to collect generic drug user fees for future FYs. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that before FDA begins negotiations with the regulated industry on GDUFA reauthorization, we publish a notice in the Federal Register requesting public input on the reauthorization; hold a public meeting at which the public may present its views on the reauthorization, including specific suggestions for changes to the goals referred to in the GDUFA Reauthorization Performance Goals and Program Enhancements Fiscal Years 2023-2027 (i.e., the GDUFA III Commitment Letter) (https://www.fda.gov/industry/ generic-drug-user-fee-amendments/gdufa-iii-reauthorization); provide a period of 30 days after the public meeting to obtain written comments from the public; and publish the comments on FDA's website. FDA invites public comment on the GDUFA program and suggestions regarding the features FDA should propose for the next GDUFA program cycle. These comments will be published and available on FDA's website.

Learn More
Notice 19 May 2025 regulatory compliance, energy, environmental assessment, project relicensing, hydropower

⚡Spencer Mountain Hydropower Relicensing

The Department of Energy announces the revised procedural schedule for the environmental assessment concerning the relicensing of Spencer Mountain Hydropower, LLC’s 0.64-megawatt project. This includes anticipated key milestones, particularly the issuance of the environmental assessment, essential for evaluating the project's impact and ensuring compliance with regulatory standards.

Learn More
Notice 19 May 2025 healthcare research, health insurance, regulatory compliance, data collection, employer-sponsored coverage

📊Agency Information Collection on Healthcare Research Comments Open

This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve an extension of the currently approved information collection "Medical Expenditures Panel Survey-- Insurance Component, (OMB No. 0935-0110)." This proposed information collection was previously published in the Federal Register on November 13, 2024 and allowed 60 days for public comment. AHRQ received comments from members of the public. The purpose of this notice is to allow an additional 30 days for public comment.

Learn More
Proposed Rule 19 May 2025 regulatory compliance, aviation, airline industry, safety, air transportation, aviation safety, airbus, aircraft, faa, incorporation by reference, airworthiness

✈️Proposed Airworthiness Directive for Airbus Airplanes Compliance

The FAA proposes to adopt a new airworthiness directive (AD) for certain Airbus SAS Model A319-112 and -132 airplanes, and Model A320-214, -232, -233, -251N, and -271N airplanes. This proposed AD was prompted by rivet holes being left unplugged after bracket relocation or removal accomplished during certain modifications, potentially resulting in fatigue damage starting from those rivet holes. This proposed AD would require a one-time special detailed inspection (SDI) of the rivet holes and applicable corrective actions; and would also allow the installation of certain modifications, provided rivets are installed after the modification; as specified in a European Union Aviation Safety Agency (EASA) AD, which is proposed for incorporation by reference (IBR). The FAA is proposing this AD to address the unsafe condition on these products.

Learn More